129 related articles for article (PubMed ID: 16775248)
1. Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs.
Moses MA; Harper J; Folkman J
N Engl J Med; 2006 Jun; 354(24):2621-2. PubMed ID: 16775248
[No Abstract] [Full Text] [Related]
2. Lymphangioleiomyomatosis.
Fernández-Fernández FJ; Buño-Ramilo B; Sesma P
Eur J Intern Med; 2009 Jan; 20(1):e24. PubMed ID: 19237077
[No Abstract] [Full Text] [Related]
3. Doxycycline use in patients with lymphangioleiomyomatosis: safety and efficacy in metalloproteinase blockade.
Pimenta SP; Baldi BG; Acencio MM; Kairalla RA; Carvalho CR
J Bras Pneumol; 2011; 37(4):424-30. PubMed ID: 21881731
[TBL] [Abstract][Full Text] [Related]
4. [Lymphangioleiomyomatosis: new therapeutic approaches].
Casanova A; Ancochea J
Arch Bronconeumol; 2011 Dec; 47(12):579-80. PubMed ID: 21924539
[No Abstract] [Full Text] [Related]
5. A 2-year randomised placebo-controlled trial of doxycycline for lymphangioleiomyomatosis.
Chang WY; Cane JL; Kumaran M; Lewis S; Tattersfield AE; Johnson SR
Eur Respir J; 2014 Apr; 43(4):1114-23. PubMed ID: 24311763
[TBL] [Abstract][Full Text] [Related]
6. The way forward in lymphangioleiomyomatosis: a trial for every patient, every patient in a trial.
McCormack FX
J Bras Pneumol; 2011; 37(4):422-3. PubMed ID: 21881730
[No Abstract] [Full Text] [Related]
7. Doxycycline: a pilot study to reduce diabetic proteinuria.
Naini AE; Harandi AA; Moghtaderi J; Bastani B; Amiran A
Am J Nephrol; 2007; 27(3):269-73. PubMed ID: 17429196
[TBL] [Abstract][Full Text] [Related]
8. A recurrent craniopharyngioma illustrates the potential usefulness of urinary matrix metalloproteinases as noninvasive biomarkers: case report.
Smith ER; Manfredi M; Scott RM; Black PM; Moses MA
Neurosurgery; 2007 Jun; 60(6):E1148-9; discussion E1149. PubMed ID: 17538362
[TBL] [Abstract][Full Text] [Related]
9. Does orally administered doxycycline reach the tear film?
Smith VA; Khan-Lim D; Anderson L; Cook SD; Dick AD
Br J Ophthalmol; 2008 Jun; 92(6):856-9. PubMed ID: 18460541
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of MMP-2 and MMP-9 leads to degradation of type IV collagen during skeletal muscle reperfusion injury; protection by the MMP inhibitor, doxycycline.
Roach DM; Fitridge RA; Laws PE; Millard SH; Varelias A; Cowled PA
Eur J Vasc Endovasc Surg; 2002 Mar; 23(3):260-9. PubMed ID: 11914015
[TBL] [Abstract][Full Text] [Related]
11. Doxycycline reduces airway inflammation and hyperresponsiveness in a murine model of toluene diisocyanate-induced asthma.
Lee KS; Jin SM; Kim SS; Lee YC
J Allergy Clin Immunol; 2004 May; 113(5):902-9. PubMed ID: 15131573
[TBL] [Abstract][Full Text] [Related]
12. Lymphangioleiomyomatosis: unsuccessful treatment with luteinizing-hormone-releasing hormone analogues.
de la Fuente J; Páramo C; Román F; Pérez R; Masa C; de Letona JM
Eur J Med; 1993; 2(6):377-8. PubMed ID: 8252188
[No Abstract] [Full Text] [Related]
13. Combined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, usp monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosacea.
Fowler JF
J Drugs Dermatol; 2007 Jun; 6(6):641-5. PubMed ID: 17668530
[TBL] [Abstract][Full Text] [Related]
14. Sirolimus treatment for recurrent lymphangioleiomyomatosis after lung transplantation.
Chen F; Omasa M; Kondo N; Fujinaga T; Shoji T; Sakai H; Bando T
Ann Thorac Surg; 2009 Jan; 87(1):e6-7. PubMed ID: 19101258
[TBL] [Abstract][Full Text] [Related]
15. Doxycycline in lymphangioleiomyomatosis: not all questions are answered.
Johnson SR; Chang WY; Tattersfield AE; Lewis S; Kumaran M; Cane JL
Eur Respir J; 2014 May; 43(5):1538. PubMed ID: 24789960
[No Abstract] [Full Text] [Related]
16. Doxycycline in lymphangioleiomyomatosis: not all questions are answered.
Baldi BG; Ribeiro Carvalho CR
Eur Respir J; 2014 May; 43(5):1536-7. PubMed ID: 24789959
[No Abstract] [Full Text] [Related]
17. [Lymphangioleiomyomatosis a rare disease in a young women].
Lommi J; Sirén J; Laine T; Purhonen M; Jeskaner L; Härkönen M
Duodecim; 1997; 113(2):149-52. PubMed ID: 11370045
[No Abstract] [Full Text] [Related]
18. [Treatment of pulmonary lymphangioleiomyomatosis using a GnRH agonist].
Desurmont S; Bauters C; Copin MC; Dewailly D; Tonnel AB; Wallaert B
Rev Mal Respir; 1996 Jul; 13(3):300-4. PubMed ID: 8765924
[TBL] [Abstract][Full Text] [Related]
19. High dose progesterone therapy in lymphangioleiomyomatosis: a case report and review of literature.
Ho AY; Lam B; Ooi CC; Tan KC; Tsang KW
Chin Med J (Engl); 1998 Aug; 111(8):759-61. PubMed ID: 11245037
[No Abstract] [Full Text] [Related]
20. Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial.
Brown DL; Desai KK; Vakili BA; Nouneh C; Lee HM; Golub LM
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):733-8. PubMed ID: 14962945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
